Early, Incomplete, or Preclinical Autoimmune Systemic Rheumatic Diseases and Pregnancy Outcome

Clicks: 339
ID: 113242
2016
In our study population, preclinical rheumatic disorders were associated with an increased risk of FGR/preeclampsia and SGA. The impact of these findings and their utility in screening for FGR/preeclampsia need to be confirmed in population studies.
Reference Key
a2016arthritisearly, Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Spinillo A;Beneventi F;Locatelli E;Ramoni V;Caporali R;Alpini C;Albonico G;Cavagnoli C;Montecucco C;;
Journal arthritis & rheumatology (hoboken, nj)
Year 2016
DOI DOI not found
URL
https://www.pubmed.gov/27158919/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine pregnancy logistic models research support non-u.s. gov't adult female Connective Tissue Diseases / epidemiology Lupus Erythematosus Systemic / epidemiology Systemic / immunology Pregnancy Complications / immunology Rheumatic Diseases / immunology Infant newborn Cohort Studies autoimmune diseases / immunology odds ratio arthritis longitudinal studies italy / epidemiology rheumatoid / epidemiology autoantibodies / immunology pmid:27158919 doi:10.1002/art.39737 arsenio spinillo fausta beneventi carlomaurizio montecucco antiphospholipid syndrome / epidemiology antiphospholipid syndrome / immunology rheumatoid / immunology autoimmune diseases / epidemiology* connective tissue diseases / immunology fetal growth retardation / epidemiology* small for gestational age pre-eclampsia / epidemiology* pregnancy complications / epidemiology* pregnancy outcome / epidemiology* pulsatile flow rheumatic diseases / epidemiology* sjogren's syndrome / epidemiology sjogren's syndrome / immunology ultrasonography doppler prenatal uterine artery / diagnostic imaging

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.